VITURA HEALTH LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.16 AUD | -5.88% |
|
-8.57% | -37.25% |
| Apr. 05 | Vitura Health JV Commences Manufacture of GMP LaNeo MDMA; Shares Up 3% | MT |
| Mar. 18 | Vitura Health Joint Venture Supplies First Psilocybin for Patient Use Outside Trial | MT |
| Sales 2022 | 66.99M 42.98M | Sales 2023 | 117M 75.28M | Capitalization | 287M 184M |
|---|---|---|---|---|---|
| Net income 2022 | 6M 3.85M | Net income 2023 | 13M 8.34M | EV / Sales 2022 | 1.89 x |
| Net cash position 2022 | 11.02M 7.07M | Net cash position 2023 | 17.57M 11.27M | EV / Sales 2023 | 2.29 x |
| P/E ratio 2022 |
20.2
x | P/E ratio 2023 |
21.3
x | Employees | - |
| Yield 2022 |
4% | Yield 2023 |
1.94% | Free-Float | 25.01% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -5.88% | ||
| 1 week | -8.57% | ||
| Current month | -15.79% | ||
| 1 month | +6.67% | ||
| 3 months | -34.69% | ||
| 6 months | -57.89% | ||
| Current year | -37.25% |
1 week
0.16
0.19
1 month
0.160.22
Current year
0.130.29
1 year
0.130.60
3 years
0.101.04
5 years
0.071.04
10 years
0.071.04
| Managers | Title | Age | Since |
|---|---|---|---|
Rodney Cocks
CEO | Chief Executive Officer | - | 18-09-26 |
| Director of Finance/CFO | 60 | 18-12-02 | |
Kirsty Garrett
COO | Chief Operating Officer | - | 23-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rodney Cocks
CEO | Chief Executive Officer | - | 18-09-26 |
Robert Iervasi
CHM | Chairman | - | Feb. 12 |
Guy Headley
BRD | Director/Board Member | - | 21-12-15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 0.16 | -5.88% | 35 346 |
| 24-04-18 | 0.17 | 0.00% | 79,348 |
| 24-04-17 | 0.17 | +3.03% | 58,324 |
| 24-04-16 | 0.165 | +3.13% | 91,283 |
| 24-04-15 | 0.16 | -8.57% | 264,484 |
Delayed Quote Australian S.E., April 19, 2024 at 01:45 am EDT
More quotes
Vitura Health Limited is a diversified digital health company that operates various businesses via its subsidiaries CanView, Doctors on Demand, Cortexa, CDA Clinics, Cannadoc, BHC and Adaya. It consists of Medical segment involving the sale and distribution of medicinal cannabis products; Clinics segment involving the operation of medicinal cannabis clinics, and Consumer segment involving the sale of consumer (non-medical) products in both Australia and Asia. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy and supplier online platform, CanView, which sells and distributes 350+ therapeutic products and device stock-keeping units (SKUs) within Australia from medicinal cannabis producers. It also owns Doctors on Demand Pty Ltd, a telehealth platform business that provides primary health solutions. It owns 75.5% Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes telehealth consultations with patients seeking access to medicinal cannabis.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -37.25% | 63.04M | |
| +40.29% | 6.16B | |
| -15.73% | 4.49B | |
| -9.40% | 3.17B | |
| -1.60% | 3.01B | |
| -1.23% | 2.57B | |
| +34.89% | 1.8B | |
| -11.37% | 1.62B | |
| -5.02% | 1.56B | |
| -13.21% | 1.53B |
- Stock Market
- Equities
- VIT Stock
